GLP-1 RAs can effectively lower blood glucose levels and facilitate weight loss with a low risk of hypoglycemia; hence, they are commonly used in patients with type 2 diabetes mellitus (T2DM). The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.